Complex interactions in Parkinson's disease: A two‐phased approach
Identifieur interne : 001E32 ( Istex/Curation ); précédent : 001E31; suivant : 001E33Complex interactions in Parkinson's disease: A two‐phased approach
Auteurs : Demetrius M. Maraganore [États-Unis] ; Mariza De Andrade [États-Unis] ; Timothy G. Lesnick [États-Unis] ; Matthew J. Farrer [États-Unis] ; James H. Bower [États-Unis] ; John A. Hardy [États-Unis] ; Walter A. Rocca [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2003-06.
English descriptors
- KwdEn :
Abstract
The identification of pathogenic mutations in the three genes α‐synuclein, parkin, and ubiquitin carboxy‐terminal hydrolase L1 (UCHL1) has elucidated the ubiquitin proteasome system (UPS) and its potential role as a causal pathway in Parkinson's disease (PD). In addition, polymorphisms of these three genes have been shown to be independently associated with PD. In a sample of 298 unrelated PD cases and 185 controls, we applied a two‐phased approach of recursive partitioning and logistic regression analyses to explore complex interactions. For women only, we observed an epistatic interaction of UCHL1 and α‐synuclein genotypes with significant effects on PD risk (odds ratio = 2.42; P = 0.003). Our findings are consistent with the hypothesis that PD is a multigenic disorder of the UPS. © 2003 Movement Disorder Society
Url:
DOI: 10.1002/mds.10431
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001E32
Links to Exploration step
ISTEX:6D2F0F2002A2C9CA6122A9E865C7C8B5D95EB5E0Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Complex interactions in Parkinson's disease: A two‐phased approach</title><author><name sortKey="Maraganore, Demetrius M" sort="Maraganore, Demetrius M" uniqKey="Maraganore D" first="Demetrius M." last="Maraganore">Demetrius M. Maraganore</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea></affiliation></author><author><name sortKey="De Andrade, Mariza" sort="De Andrade, Mariza" uniqKey="De Andrade M" first="Mariza" last="De Andrade">Mariza De Andrade</name><affiliation wicri:level="1"><mods:affiliation>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea></affiliation></author><author><name sortKey="Lesnick, Timothy G" sort="Lesnick, Timothy G" uniqKey="Lesnick T" first="Timothy G." last="Lesnick">Timothy G. Lesnick</name><affiliation wicri:level="1"><mods:affiliation>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea></affiliation></author><author><name sortKey="Farrer, Matthew J" sort="Farrer, Matthew J" uniqKey="Farrer M" first="Matthew J." last="Farrer">Matthew J. Farrer</name><affiliation wicri:level="1"><mods:affiliation>Department of Neuroscience, Mayo Clinic and Mayo Foundation, Jacksonville, Florida, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neuroscience, Mayo Clinic and Mayo Foundation, Jacksonville, Florida</wicri:regionArea></affiliation></author><author><name sortKey="Bower, James H" sort="Bower, James H" uniqKey="Bower J" first="James H." last="Bower">James H. Bower</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea></affiliation></author><author><name sortKey="Hardy, John A" sort="Hardy, John A" uniqKey="Hardy J" first="John A." last="Hardy">John A. Hardy</name><affiliation wicri:level="1"><mods:affiliation>Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland</wicri:regionArea></affiliation></author><author><name sortKey="Rocca, Walter A" sort="Rocca, Walter A" uniqKey="Rocca W" first="Walter A." last="Rocca">Walter A. Rocca</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:6D2F0F2002A2C9CA6122A9E865C7C8B5D95EB5E0</idno><date when="2003" year="2003">2003</date><idno type="doi">10.1002/mds.10431</idno><idno type="url">https://api.istex.fr/document/6D2F0F2002A2C9CA6122A9E865C7C8B5D95EB5E0/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001E32</idno><idno type="wicri:Area/Istex/Curation">001E32</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Complex interactions in Parkinson's disease: A two‐phased approach</title><author><name sortKey="Maraganore, Demetrius M" sort="Maraganore, Demetrius M" uniqKey="Maraganore D" first="Demetrius M." last="Maraganore">Demetrius M. Maraganore</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea></affiliation></author><author><name sortKey="De Andrade, Mariza" sort="De Andrade, Mariza" uniqKey="De Andrade M" first="Mariza" last="De Andrade">Mariza De Andrade</name><affiliation wicri:level="1"><mods:affiliation>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea></affiliation></author><author><name sortKey="Lesnick, Timothy G" sort="Lesnick, Timothy G" uniqKey="Lesnick T" first="Timothy G." last="Lesnick">Timothy G. Lesnick</name><affiliation wicri:level="1"><mods:affiliation>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea></affiliation></author><author><name sortKey="Farrer, Matthew J" sort="Farrer, Matthew J" uniqKey="Farrer M" first="Matthew J." last="Farrer">Matthew J. Farrer</name><affiliation wicri:level="1"><mods:affiliation>Department of Neuroscience, Mayo Clinic and Mayo Foundation, Jacksonville, Florida, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neuroscience, Mayo Clinic and Mayo Foundation, Jacksonville, Florida</wicri:regionArea></affiliation></author><author><name sortKey="Bower, James H" sort="Bower, James H" uniqKey="Bower J" first="James H." last="Bower">James H. Bower</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea></affiliation></author><author><name sortKey="Hardy, John A" sort="Hardy, John A" uniqKey="Hardy J" first="John A." last="Hardy">John A. Hardy</name><affiliation wicri:level="1"><mods:affiliation>Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland</wicri:regionArea></affiliation></author><author><name sortKey="Rocca, Walter A" sort="Rocca, Walter A" uniqKey="Rocca W" first="Walter A." last="Rocca">Walter A. Rocca</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2003-06">2003-06</date><biblScope unit="vol">18</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="631">631</biblScope><biblScope unit="page" to="636">636</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">6D2F0F2002A2C9CA6122A9E865C7C8B5D95EB5E0</idno><idno type="DOI">10.1002/mds.10431</idno><idno type="ArticleID">MDS10431</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>epistasis</term><term>interactions</term><term>recursive partitioning</term><term>susceptibility genes</term><term>ubiquitin proteasome system</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The identification of pathogenic mutations in the three genes α‐synuclein, parkin, and ubiquitin carboxy‐terminal hydrolase L1 (UCHL1) has elucidated the ubiquitin proteasome system (UPS) and its potential role as a causal pathway in Parkinson's disease (PD). In addition, polymorphisms of these three genes have been shown to be independently associated with PD. In a sample of 298 unrelated PD cases and 185 controls, we applied a two‐phased approach of recursive partitioning and logistic regression analyses to explore complex interactions. For women only, we observed an epistatic interaction of UCHL1 and α‐synuclein genotypes with significant effects on PD risk (odds ratio = 2.42; P = 0.003). Our findings are consistent with the hypothesis that PD is a multigenic disorder of the UPS. © 2003 Movement Disorder Society</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E32 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 001E32 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:6D2F0F2002A2C9CA6122A9E865C7C8B5D95EB5E0
|texte= Complex interactions in Parkinson's disease: A two‐phased approach
}}
| This area was generated with Dilib version V0.6.23. |  |